ClinicalTrials.govpublic full text
Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy
prostate cancer metastatic to bone, bone metastases, rhenium-188-hedp, radium 223-chloride, survival, prostate cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 881653
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.